GLMD
Price
$0.66
Change
+$0.06 (+10.00%)
Updated
Feb 6 closing price
Capitalization
3.71M
51 days until earnings call
Intraday BUY SELL Signals
MREO
Price
$0.42
Change
+$0.04 (+10.53%)
Updated
Feb 6 closing price
Capitalization
67.55M
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLMD vs MREO

Header iconGLMD vs MREO Comparison
Open Charts GLMD vs MREOBanner chart's image
Galmed Pharmaceuticals
Price$0.66
Change+$0.06 (+10.00%)
Volume$176.47K
Capitalization3.71M
Mereo BioPharma Group
Price$0.42
Change+$0.04 (+10.53%)
Volume$4.39M
Capitalization67.55M
GLMD vs MREO Comparison Chart in %
GLMD
Daily Signal:
Gain/Loss:
MREO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLMD vs. MREO commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a Hold and MREO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (GLMD: $0.66 vs. MREO: $0.42)
Brand notoriety: GLMD and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 161% vs. MREO: 22%
Market capitalization -- GLMD: $3.71M vs. MREO: $67.55M
GLMD [@Biotechnology] is valued at $3.71M. MREO’s [@Biotechnology] market capitalization is $67.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 1 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • GLMD’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than GLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 4 TA indicator(s) are bullish while MREO’s TA Score has 4 bullish TA indicator(s).

  • GLMD’s TA Score: 4 bullish, 4 bearish.
  • MREO’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, MREO is a better buy in the short-term than GLMD.

Price Growth

GLMD (@Biotechnology) experienced а -6.49% price change this week, while MREO (@Biotechnology) price change was -3.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

GLMD is expected to report earnings on Apr 01, 2026.

MREO is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($67.6M) has a higher market cap than GLMD($3.71M). MREO YTD gains are higher at: 1.872 vs. GLMD (-11.539). GLMD has higher annual earnings (EBITDA): -7.11M vs. MREO (-40.14M). MREO has more cash in the bank: 48.7M vs. GLMD (19.1M). GLMD has less debt than MREO: GLMD (41K) vs MREO (397K). MREO has higher revenues than GLMD: MREO (500K) vs GLMD (0).
GLMDMREOGLMD / MREO
Capitalization3.71M67.6M5%
EBITDA-7.11M-40.14M18%
Gain YTD-11.5391.872-616%
P/E Ratio0.02N/A-
Revenue0500K-
Total Cash19.1M48.7M39%
Total Debt41K397K10%
FUNDAMENTALS RATINGS
GLMD vs MREO: Fundamental Ratings
GLMD
MREO
OUTLOOK RATING
1..100
5092
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9366
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (32) in the Pharmaceuticals Other industry is in the same range as MREO (50) in the null industry. This means that GLMD’s stock grew similarly to MREO’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MREO (100) in the null industry. This means that GLMD’s stock grew similarly to MREO’s over the last 12 months.

GLMD's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as MREO (98) in the null industry. This means that GLMD’s stock grew similarly to MREO’s over the last 12 months.

MREO's Price Growth Rating (66) in the null industry is in the same range as GLMD (93) in the Pharmaceuticals Other industry. This means that MREO’s stock grew similarly to GLMD’s over the last 12 months.

GLMD's P/E Growth Rating (96) in the Pharmaceuticals Other industry is in the same range as MREO (100) in the null industry. This means that GLMD’s stock grew similarly to MREO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMDMREO
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 27 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLMD
Daily Signal:
Gain/Loss:
MREO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRI2.390.20
+9.13%
GRI Bio Inc.
TRMD24.900.76
+3.15%
TORM plc
MAS72.871.76
+2.48%
Masco Corp
YHNA10.660.01
+0.09%
YHN Acquisition I Ltd
CIVB24.83-0.04
-0.16%
Civista Bancshares

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with ARTV. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+11.58%
ARTV - GLMD
68%
Closely correlated
+4.13%
TPST - GLMD
67%
Closely correlated
+7.62%
MREO - GLMD
65%
Loosely correlated
+13.20%
RZLT - GLMD
64%
Loosely correlated
+6.85%
IMRN - GLMD
63%
Loosely correlated
+3.31%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with ARTV. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+13.20%
ARTV - MREO
89%
Closely correlated
+4.13%
VTGN - MREO
87%
Closely correlated
+11.52%
QNCX - MREO
85%
Closely correlated
-4.79%
TPST - MREO
84%
Closely correlated
+7.62%
RZLT - MREO
82%
Closely correlated
+6.85%
More